editorial | Q871232 |
scholarly article | Q13442814 |
P50 | author | Sanjay Kalra | Q80639815 |
P2093 | author name string | Rajeev Chawla | |
S V Madhu | |||
P2860 | cites work | Stress and hormones | Q24611729 |
Bromocriptine in type 2 diabetes mellitus | Q35153082 | ||
Renin-angiotensin system activity in vitamin D deficient, obese individuals with hypertension: An urban Indian study | Q35590943 | ||
Testosterone and metabolic syndrome: The link | Q35968107 | ||
Iron intake, haemoglobin and risk of gestational diabetes: a prospective cohort study | Q36307036 | ||
Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus | Q37141727 | ||
Obesogens | Q37778256 | ||
An update on the islet renin-angiotensin system | Q37852286 | ||
Dopamine: the forgotten felon in type 2 diabetes | Q37954769 | ||
Management of diabetic hypertensives | Q39581591 | ||
Adrenergic India: Managing its diabetes | Q42858950 | ||
Divalent Metal Transporter 1 Regulates Iron-Mediated ROS and Pancreatic β Cell Fate in Response to Cytokines | Q58201140 | ||
P433 | issue | 3 | |
P304 | page(s) | 367-369 | |
P577 | publication date | 2013-05-01 | |
P1433 | published in | Indian Journal of Endocrinology and Metabolism | Q15816442 |
P1476 | title | The dirty dozen of diabetes | |
P478 | volume | 17 |
Q28068120 | Adenosine monophosphate-activated protein kinase-based classification of diabetes pharmacotherapy |
Q90733533 | Defining Disease Progression and Drug Durability in Type 2 Diabetes Mellitus |
Q91728002 | Discharge pharmacotherapy for Type 2 diabetic inpatients at two hospitals of different tiers in Zhejiang Province, China |
Q90221395 | Euthymia in Diabetes: Clinical Evidence and Practice-Based Opinion from an International Expert Group |
Q64996887 | Post-immunotherapy new onset diabetes (PINOD)-under-recognized etiology, unexplored presentation. |
Q34642449 | Pregnancy and the formative fifteen of diabetes |